Alkeon Capital Management’s Relmada Therapeutics RLMD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-100,000	Closed	-$2.62M	–	156
2021 Q3	$2.62M	Buy	100,000 +50,000	+100%	+$1.31M	﹤0.01%	152
2021 Q2	$1.6M	Hold	50,000	–	–	﹤0.01%	144
2021 Q1	$1.76M	Hold	50,000	–	–	﹤0.01%	139
2020 Q4	$1.6M	Buy	+50,000	New	+$1.6M	﹤0.01%	131